遗传变异揭示了一个同源的长非编码RNA,该RNA调节人类造血干细胞
Peng Lyu1,2,3,4, Gaurav Agarwal1,2,3,4, Chun-Jie Guo1,2,3,4
1Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
bioRxiv : the preprint server for biology
|August 12, 2025
概括
一种新发现的基因变体rs17437411通过破坏一种名为HOTSCRAMBL的新型长非编码RNA,影响血液细胞数量和癌症风险. 这一发现揭示了一种调节干细胞中HOXA基因表达的新机制.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 血液学 血液学 血液学
背景情况:
- HOXA基因位点对于发育,造血和分化至关重要.
- 在HOXA位点内的遗传变异可以影响血细胞表型和疾病易感性.
研究的目的:
- 为了研究一种特定的遗传变异 (rs17437411) 与血液细胞计数变异和癌症保护相关的功能影响.
- 确定和描述一种参与调节HOXA基因表达的新型长非编码RNA (lncRNA).
主要方法:
- 对与血液表型相关的人类遗传变异数据的分析.
- 一种新的反感 lncRNA (HOTSCRAMBL) 的识别和功能特征.
- 测试以评估变异对造血干细胞 (HSC) 自更新和HOXA基因表达的影响,包括SRSF2-依赖拼接.
主要成果:
- 这种基因变异rs17437411破坏了HOTSCRAMBL lncRNA的功能.
- 破坏HOTSCRAMBL会减少人体HSC的自我更新,并损害HOXA基因表达,特别是HOXA9.
- 热功能障碍会影响HOXA依赖性急性髓性白血病.
结论:
- 人类遗传变异可以揭示基因表达中的关键调节途径.
- 热是高细胞中HOXA基因表达的关键调节者,影响血液形成和白血病发生.
- 了解HOTSCRAMBL的作用可以了解血液疾病和潜在的治疗点.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Hematopoiesis
5.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
RNA Splicing
57.0K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
57.0K


